Medicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder. Objectives: ...

Medicare Part D or Part C plans with drug coverage may cover Suboxone, a medication used to treat opioid use disorder (OUD). If you receive the drug as an inpatient or in a clinic with the help of a ...

Indivior, a pharmaceutical company, has reached a $30 million settlement to resolve a class action lawsuit filed in a U.S. court by health plans. The lawsuit alleges that the company unlawfully ...

Dr. Reddy’s Laboratories, a generic drug maker with U.S. headquarters in Princeton Junction, has won U.S. Food and Drug Administration approval to sell a generic version of Suboxone sublingual film, a ...

NEW YORK--(BUSINESS WIRE)--MedicaSafe, Inc. today announced a partnership with Amneal Pharmaceuticals, Inc. (NYSE: AMRX) to provide Amneal’s generic version of Suboxone ® (buprenorphine and naloxone) ...

Chesterfield County-based pharmaceutical manufacturer Indivior Inc. has reached a $30 million settlement agreement in a federal class-action antitrust lawsuit brought by a group of health plans over ...

U.S. regulators have approved the first generic version of an under-the-tongue film for treating opioid addiction. The Food and Drug Administration on Thursday approved a generic version of Suboxone, ...

(Reuters) - Indivior's U.S. subsidiary has filed lawsuits against firms seeking approval for generic versions of its opioid addiction treatment Suboxone, which generates 80 percent of the drugmaker's ...